Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr;36(4):424-433.
doi: 10.1111/dme.13868. Epub 2018 Dec 7.

The unmet need for better risk stratification of non-proliferative diabetic retinopathy

Affiliations
Review

The unmet need for better risk stratification of non-proliferative diabetic retinopathy

S Sivaprasad et al. Diabet Med. 2019 Apr.

Abstract

Diabetic retinopathy is a common microvascular complication of diabetes and remains one of the leading causes of preventable blindness in working-age people. Non-proliferative diabetic retinopathy is the earliest stage of diabetic retinopathy and is typically asymptomatic. Currently, the severity of diabetic retinopathy is assessed using semi-quantitative grading systems based on the presence or absence of retinal lesions. These methods are well validated, but do not predict those at high risk of rapid progression to sight-threatening diabetic retinopathy; therefore, new approaches for identifying these people are a current unmet need. We evaluated published data reporting the lesion characteristics associated with different progression profiles in people with non-proliferative diabetic retinopathy. Based on these findings, we propose that additional assessments of features of non-proliferative diabetic retinopathy lesions may help to stratify people based on the likelihood of rapid progression. In addition to the current classification, the following measurements should be considered: the shape and size of lesions; whether lesions are angiogenic in origin; the location of lesions, including predominantly peripheral lesions; and lesion turnover and dynamics. For lesions commonly seen in hypertensive retinopathy, a detailed assessment of potential concomitant diseases is also recommended. We believe that natural history studies of these changes will help characterize these non-proliferative diabetic retinopathy progression profiles and advance our understanding of the pathogenesis of diabetic retinopathy in order to individualize management of people with diabetic retinopathy.

PubMed Disclaimer

References

    1. International Diabetes Federation . IDF Diabetes Atlas. 8th edn. 2017. Available at http://www.diabetesatlas.org/ Last accessed 26 June 2018.
    1. Liu Y, Yang J, Tao L, Lv H, Jiang X, Zhang M et al Risk factors of diabetic retinopathy and sight‐threatening diabetic retinopathy: a cross‐sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China. BMJ Open 2017; 7: e016280. - PMC - PubMed
    1. Ahsan H. Diabetic retinopathy –biomolecules and multiple pathophysiology. Diabetes Metab Syndr 2015; 9: 51–54. - PubMed
    1. Santos AR, Ribeiro L, Bandello F, Lattanzio R, Egan C, Frydkjaer‐Olsen U et al Functional and structural findings of neurodegeneration in early stages of diabetic retinopathy: cross‐sectional analyses of baseline data of the EUROCONDOR project. Diabetes 2017; 66: 2503–2510. - PubMed
    1. Curtis TM, Gardiner TA, Stitt AW. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye (Lond) 2009; 23: 1496–1508. - PubMed

Publication types

MeSH terms